ArticleFrontiers in oncology2025
A patient with recurrent pelvic bone metastasis after gastric cancer surgery achieved long-term survival: a case report.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: After gastric cancer surgery, solitary bone metastasis is very rare, and repeated pelvic metastasis has not been reported. This article reports a case of recurrent pelvic metastasis after early gastric cancer surgery, in which the patient achieved long-term survival through multiple aggressive surgeries, radiation therapy, and systemic treatment. Case Presentation: This article reports on a 67-year-old male who presented with "6 days of black stools and 2 days of fatigue." Gastric endoscopy biopsy indicated gastric cancer, and after completing preoperative examinations, he underwent surgical treatment. The patient experienced recurrent pelvic metastases after gastric cancer surgery and underwent multiple surgeries, combined with radiotherapy and chemotherapy. In the end, he achieved long-term survival of 56 months. Conclusions: For gastric cancer patients with isolated bone metastases, active surgery in combination with other treatment options can be taken. With the goal of reducing symptoms, improvement in quality of life and survival can be achieved.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.